Best Healthcare &amp; Medical Stocks

Early Lung Cancer Treatment Tests Give Pfizer (NYSE:PFE) a Leg Up

Drugmaker Pfizer (NYSE:PFE) has been on the ropes for some time now since it lost its COVID-19 gravy...

2d ago

Amedisys sinks into potential extension of UnitedHealth deal review

Shares of Amedisys (AMED) are moving lower into a potential regulatory update on the company’s pending takeover by...

2d ago

UNH

AMED

Johnson & Johnson completes Shockwave acquisition, sees EPS dilution

Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson...

2d ago

Novartis announces its Phase III study of Scemblix showed ‘superior efficacy’

Novartis presents results from the pivotal Phase III ASC4FIRST trial as a late-breaking abstract at the 2024 American...

2d ago

Pfizer announces follow-up results from CROWN trial

Pfizer announced longer-term follow-up results from the Phase 3 CROWN trial evaluating Lorbrena, a third-generation ALK inhibitor, available...

2d ago

ZTS, SYK, LLY: Which Healthcare Stock Is the Best Buy?

The following healthcare picks —ZTS, SYK, LLY— have solid fundamentals and resilient enough growth profiles to be worthy...

3d ago

Structure Therapeutics (NASDAQ:GPCR): Analysts See 130% Upside in This GLP-1 Stock

SYK

There’s a new name looking to stake its claim to the GLP-1 goldmine, and analysts say the stock...

3d ago

Novartis says Phase III data confirm efficacy, safety of oral remibrutinib

NVO

Novartis announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective Bruton’s tyrosine...

3d ago

Vanda Pharma completes transfer of FDA Marketing Authorization for Ponvory

Vanda Pharmaceuticals (VNDA) announced that ownership of the U.S. New Drug Application and Investigational New Drug Applications for...

3d ago

VNDA

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Healthcare Stocks

Eli Lilly & Co

Buy

Assigned

2024-05-31

TDOC

Teladoc

Hold

Assigned

2024-05-31

Johnson & Johnson

Hold

Initiated

2024-05-30

CVS

CVS Health

Buy

Reiterated

2024-05-30

UNH

UnitedHealth

Buy

Reiterated

2024-05-30

Pfizer

Hold

Reiterated

2024-05-30

ABT

Abbott Laboratories

Buy

Initiated

2024-05-30

Novartis

Hold

Reiterated

2024-05-17

RHHBY

Roche Holding

Hold

Reiterated

2024-04-08

Eli Lilly & Co

Hold

Assigned

2024-05-30

All Ratings >

Most Recent Earnings of Healthcare Stocks

Pfizer

May 01, 2024

Mar 01, 2024

0.52 / 0.82

0.67

Novartis

Apr 23, 2024

Mar 01, 2024

1.68 / 1.80

1.734

Johnson & Johnson

Apr 16, 2024

Mar 01, 2024

2.66 / 2.71

2.8

RHHBY

Roche Holding

Feb 01, 2024

Dec 01, 2023

1.22 / 1.23

4.96

ABT

Abbott Laboratories

Apr 17, 2024

Mar 01, 2024

0.95 / 0.98

1.08

Eli Lilly & Co

Apr 30, 2024

Mar 01, 2024

2.47 / 2.58

2.11

CVS

CVS Health

May 01, 2024

Mar 01, 2024

1.70 / 1.31

2.21

UNH

UnitedHealth

Apr 16, 2024

Mar 01, 2024

6.61 / 6.91

6.14

TDOC

Teladoc

Apr 25, 2024

Mar 01, 2024

-0.46 / -0.49

-0.4

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?

These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:

Abbott Laboratories - Strong Buy, based on 11 analyst ratings, 10 Buy, 1 Hold, and 0 Sell.

Eli Lilly & Co - Strong Buy, based on 20 analyst ratings, 18 Buy, 2 Hold, and 0 Sell.

UnitedHealth - Strong Buy, based on 21 analyst ratings, 17 Buy, 4 Hold, and 0 Sell.

Are Healthcare stocks overpriced?

Pfizer's stock price is currently $28.66, and its average 12-month price target is $32.79.

Novartis's stock price is currently $103.13, and its average 12-month price target is $119.00.

Johnson & Johnson's stock price is currently $146.67, and its average 12-month price target is $175.21.

Roche Holding's stock price is currently $32.01, and its average 12-month price target is $40.00.

Abbott Laboratories's stock price is currently $102.19, and its average 12-month price target is $127.09.

Eli Lilly & Co's stock price is currently $820.34, and its average 12-month price target is $886.56.

CVS Health's stock price is currently $59.60, and its average 12-month price target is $69.75.

UnitedHealth's stock price is currently $495.37, and its average 12-month price target is $559.16.

Teladoc's stock price is currently $11.24, and its average 12-month price target is $16.91.

Which Healthcare stocks pay dividends?

Pfizer does not currently pay dividends.

Novartis does not currently pay dividends.

Johnson & Johnson does not currently pay dividends.

Roche Holding does not currently pay dividends.

Abbott Laboratories does not currently pay dividends.

Eli Lilly & Co does not currently pay dividends.

CVS Health does not currently pay dividends.

UnitedHealth does not currently pay dividends.

Teladoc does not currently pay dividends.

Latest News

Demand for Electric Power Puts Pressure on Sunnova Energy International (NYSE:NOVA)

NOVA

Leslie’s (NASDAQ:LESL); From Unprecedented Surge to Industry Decline

LESL

Brookfield Business Partners (NYSE:BBU): An Opportunity Despite Recent Decline

BBU

The Week That Was, The Week Ahead: Macro & Markets, June 2, 2024

CRM

GPS

3 Economic Events That Could Affect Your Portfolio This Week, June 3 – 7, 2024

NDX

SPX

Roku Stock: Wall Street is Divided on the Streaming Platform’s Prospects

AMZN

ROKU

BTI Stock (NYSE:BTI): Michael Burry’s Biggest Position No One’s Talking About

Lifeway Foods Stock (NASDAQ:LWAY): The Next Hidden Gem in the CPG Space?

BRBR

CELH

Stock Market News Today, 5/31/24 – Indices Close Mixed amid PCE Data, GDP Estimates

NDX

SPX

Sony (NYSE:SONY) Snaps Up on State of Play, AI Plans

PARA

SONY

M&A News: Paramount (NASDAQ:PARA) Committee Gets Behind Skydance Deal, Shares Slip

APO

PARA

Intel (NASDAQ:INTC) Gains Slightly as It Looks to Expand AI

INTC

Trump Media Stock (NASDAQ:DJT): Be Nimble During Verdict Volatility

DJT

USD-JPY’s Wild Ride Through Economic Chaos